Cargando…
BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
We evaluated neutralizing antibodies against the Omicron variant and Anti-Spike IgG response in solid organ (SOT) or hematopoietic stem cell (HSTC) recipients after a third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. In total, 95 participants underwent SOT (n = 62; 44 liver,...
Autores principales: | Erol, Çiğdem, Kuloğlu, Zeynep Ece, Kayaaslan, Bircan, Esken, Gülen, Altunsoy, Adalet, Barlas, Tayfun, Çınar, Güle, Hasanoğlu, İmran, Oruç, Ebru, İncir, Said, Azap, Alpay, Korkmaz, Gülten, Turan Gökçe, Dilara, Kırımker, Onur Elvan, Coşkun Yenigün, Ezgi, Ölçücüoğlu, Erkan, Ayvazoğlu Soy, Ebru, Çetinkünar, Süleyman, Kurt Azap, Özlem, Can, Füsun, Haberal, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383925/ https://www.ncbi.nlm.nih.gov/pubmed/37515220 http://dx.doi.org/10.3390/v15071534 |
Ejemplares similares
-
Anaphylaxis is rare due to CoronaVac in a population of healthcare workers
por: Öztürk, Betül Özdel, et al.
Publicado: (2022) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination
por: Oskay, T., et al.
Publicado: (2021) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023) -
A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac
por: Mok, Chris Ka Pun, et al.
Publicado: (2022)